Clinical Evaluation of Pramipexole in Advanced Parkinson's Disease
Neurol 49:162-168, Lieberman,A.,et al, 1997
Efficacy of Pramipexole, A Novel Dopamine Agonist, As Monotherapy in Mild to Moderate Parkinson's Disease
Neurol 49:724-728, Shannon,K.M.,et al, 1997
Pharmacologic Profile of Ropinirole:A Nonergoline Dopamine Agonist
Neurol 49:558-562, Tulloch,I.F., 1997
Ropinirole for the Treatment of Early Parkinson's Disease
Neurol 49:393-399, Adler,C.H.,et al, 1997
Continuous Bromocriptine Therapy in Menstrual Migraine
Neurol 48:101-102, Herzog,A.G., 1997
Prognosis in Familial ALS:Progr & Surv in Pts with glu100gly & ala4val Mutations in Cu, Zn Superoxide Dismutase
Neurol 48:55-57, Juneja,T.,et al, 1997
ALS & Severe Cervical Spondylotic Myelopathy in Pt with a Posterior Fossa Archnoid Cyst:Diag Dilemma
South Medical J 80:1580-1583, Lee,S.K.&Kelly,D.L., 1997
Double-Blind Comparison of Pramipexole & Bromocriptine Trtm with Placebo in Advanced Parkinson's Disease
Neurol 49:1060-1065, Guttman,M.,et al, 1997
Motor Involvement in Acute Herpes Zoster
Muscle & Nerve 20:1433-1438997., Haanpaa,M.,et al, 1997
Needle Electromyography in the Thoracic Paraspinal Muscles of Motor Neuron Disease
No to Shinkei-Brain & Nerve 48:637-642996., Kyuno,K.,et al, 1996
Motor Neuron Disease, Lymphoproliferative Disease, and Bone Marrow Biopsy
Muscle & Nerve 19:1334-1337996., Louis,E.D.,et al, 1996
Immunoassays Fail to Detect Antibodies Against Neuronal Calcium Channels in Amyotrophic Lateral Sclerosis Serum
Ann Neurol 40:695-700, 6911996., Arsac,C.,et al, 1996
Chiasmal Herniation as a Complication of Bromocriptine Therapy
J Neuro-Ophthalmol 16:252-257, Taxel,P.,et al, 1996
Diagnosis of Creutzfeldt-Jakob Disease in Two-Dimensional Gel Electrophoresis of Cerebrospinal Fluid
Lancet 348:846-849, Zerr,I.,et al, 1996
Restless Legs Syndrome:Clinicoetiologic Correlates
Neurol 47:1435-1441, Ondo,W.&Jankovic,J., 1996
Motor Neuron Disease:A Paraneoplastic Process Associated with Anti-Hu Antibody and Small-Cell Lung Carcinoma
Ann Neurol 40:112-116, Verma,A.,et al, 1996
Multicenter, Placebo-Controlled Trial of Cabergoline Taken Once Daily in the Treatment of Parkinson's Disease
Neurol 46:1062-1065, Hutton,J.T.,et al, 1996
Double-Blind Comparison of Cabergoline & Bromocriptine in Parkinson's Disease Pts with Motor Fluctuations
Neurol 47:785-788, Inzelberg,R.,et al, 1996
Development of General Weakness in a Patient with Amyotrophic Lateral Sclerosis after Focal Botulinum Toxin Injection
Neurol 46:845-846, Mezaki,T.,et al, 1996
Motor Neuron Disease with Parkinsonism
Arch Neurol 53:987-991, Qureshi,A.I.,et al, 1996
From Enigmatic to Problematic:The New Molecular Genetics of Childhood Spinal Muscular Atrophy
Neurol 46:335-340, Crawford,T.O., 1996
Bromocriptine and Postpartum Cerebral Angiopathy:A Causal Relationship
Neurol 46:1754-1756, Comabella,M.,et al, 1996
Presynaptic Dopaminergic Deficits in Lesch-Nyhan Disease
NEJM 334:1568-1572, 16021996., Ernst,M.,et al, 1996
Palliative Care in Neurology
Neurol 46:870-872, 5981996., Bernat,J.L.,et al, 1996
Pure Motor Hand Weakness
Semin Neurol 16:75-81, Lewis,R.A., 1996
Is Chronic Respiratory Failure in Neuromuscular Diseases Worth Treating
JNNP 61:1-3, Shneerson,J.M., 1996
Adult-Onset MELAS
Stroke 27:1420-1423, Gilchrist,J.M.,et al, 1996
Inclusion Body Myositis
JNNP 60:251-255, Garlepp,M.J.&Mastaglia,F.L., 1996
Neurogenic Muscle Hypertrophy
Muscle & Nerve 19:811-818996., Gutmann,L., 1996
Brain and Spinal Cord MRI in Motor Neuron Disease
JNNP 61:314-317, Thorpe,J.W.,et al, 1996
Amyotrophic Lateral Sclerosis and Occupational History
Arch Neurol 53:730-733, Strickland,D.,et al, 1996
Avoiding False Positive Diagnoses of Motor Neuron Disease:Lessons from the Scottish Motor Neuron Disease Register
JNNP 60:147-151, Davenport,R.J.,et al, 1996
Diagnosing Motor Neurone Disease
BMJ 312:650-651, Chancellor,A.M., 1996
Motor Neuron Disease
BMJ 313:244, Shneerson,J.M., 1996
Motor Neuron Disease Presenting as Acute Respiratory Failure:A Clinical and Pathological Study
JNNP 60:455-458, Chen,R.,et al, 1996
Dose-Ranging Study of Riluzole in Amyotrophic Lateral Sclerosis
Lancet 347:1425-1431, Lacomblez,L.,et al, 1996
Skin Involvement in Amyotrophic Lateral Sclerosis
lancet 347:1226-1227, Kolde,G.,et al, 1996
Three Get Ready
Arch Neurol 53:1222-1223, Goldblatt,D., 1996
Riluzole
Lancet 348:795-799, Wokke,J., 1996
Retroperitoneal Fibrosis in a Patient with Parkinson's Disease Treated with Pergolide
Clin NeuroPharmacol 18:277-279, Jimenez-Jimenez,F.J.,et al, 1995
The Effect of Comb Oral Lysine Acetylsalicylate & Metoclopramide Compared w/Oral Sumatriptan for Migraine
Lancet 346:923-926, Tfelt-Hansen,P.,et al, 1995
Complementary Positron Emission Tomographic Studies of the Striatal Dopaminergic System in Parkinson's Disease
Arch Neurol 52:1183-1190, Antonini,A.,et al, 1995
Intramuscular Inject W/in 30 D of Immun with Oral Poliovirus Vaccine-Risk Factor for Vaccine-Assoc Paral Polio
NEJM 332:500-506, 5291995., Strebel,P.M.,et al, 1995
Drug Treatment of Parkinson's Disease
BMJ 310:575-579, Quinn,N., 1995
The Electrophysiological Study of Diff Dx Between ALS & Cervical Spondylotic Myelopathy
EMG & Clin Neurophysiology 35:231-238995., Kang,D.X.&Fan,D.S., 1995
Amyotrophic Lateral Sclerosis:Correlation of Clinical & MR Imaging Findings
Radiology 194:263-270, Cheung,G.,et al, 1995
Postpartum Cerebral Angiopathy Possibly Due to Bromocriptine Therapy
Stroke 26:128-130, Janssens,E.,et al, 1995
Cerebrospinal Fluid Concentration of Neuron-specific Enolase in Diagnosis of Creutzfeldt-Jakob Disease
Lancet 345:1609-1610, Zerr,I.,et al, 1995
Hypoglycaemia in Spinal Muscular Atrophy
Lancet 346:609-610, Bruce,A.K.,et al, 1995
Natural History in Proximal Spinal Muscular Atrophy
Arch Neurol 52:518-523, Zerres,K.&Rudnik-Schoneborn,R., 1995